Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 20, 2021 08:00 ET | Source: Neumentum, Inc.

Neumentum and NEMA Research Inc. Named to Short-List of Citeline Awards for 2021

Nominated for Most Successful Early-Phase Research MORRISTOWN, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) -- The Citeline Awards, sponsored by Informa Pharma Intelligence, today announced that Neumentum...
September 15, 2021 08:00 ET | Source: Neumentum, Inc.

Neumentum to Participate in the UBS Biotechnology Private Company Symposium

MORRISTOWN, N.J., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott...
September 08, 2021 08:00 ET | Source: Neumentum, Inc.

Neumentum Presents Latest Data on NTM-006, a Novel Non-Opioid, Non-NSAID Analgesic Drug Candidate, at PAINWeek 2021

MORRISTOWN, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced data on NTM-006,...
January 05, 2021 07:00 ET | Source: Neumentum, Inc.

Neumentum to Participate in Upcoming January Virtual Investor Conferences

MORRISTOWN, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively,...
December 08, 2020 08:00 ET | Source: Neumentum, Inc.

Neumentum to Present New Data for Drug Candidate NTM-001 at the 2020 ASHP Midyear Clinical Meeting and Exhibition

MORRISTOWN, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – will present three posters at the...
November 05, 2020 08:00 ET | Source: Neumentum, Inc.

Neumentum to Participate in the Jefferies Virtual London Healthcare Conference

MORRISTOWN, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively,...
October 21, 2020 08:00 ET | Source: Neumentum, Inc.

Neumentum and Nuance Biotech Enter into Licensing Agreement for NTM-001 (ketorolac for IV infusion) in China

MORRISTOWN, N.J., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that the company...
September 10, 2020 08:00 ET | Source: Neumentum, Inc.

Neumentum to Participate in the 18th Annual Morgan Stanley Virtual Global Healthcare Conference

MORRISTOWN, N.J., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott...
September 03, 2020 08:00 ET | Source: Neumentum, Inc.

Neumentum Announces Two Poster Presentations for Novel Non-opioid, Non-NSAID Analgesic Drug Candidate at PAINWeek 2020

MORRISTOWN, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – will present two posters with data...
July 23, 2020 08:00 ET | Source: Neumentum, Inc.

Neumentum Provides Corporate Update on Company’s Pipeline of Non-opioid Analgesic Programs

October 2020 Type C meeting planned with the FDA for NTM-006, an oral new chemical entity with a novel mechanism of action targeting neuropathic pain Based on recent FDA guidance letter,...